Article

Another SABCS comes to a close

Author(s):

Well, another great year of SABCS has come to a close. Almost 8,000 people attended the meeting, with 58 percent coming from other parts of the world. Citizens from 94 countries were counted.This symposium has truly become one of the most significant international meetings for those interested in breast cancer. I hope that our coverage of this year's symposium has made you feel that you had a "courtside" seat to all of the important data presented here. I also hope you got to know the CURE team a little better. Now, I would appreciate hearing from you! What did you like, not like about this year's coverage? What can we do better next year? Is there something that really resonated with you? We want to hear it all so we can continue to be here for you at precisely the right time, the right place and in the right format.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Related Content